Drugs / Anluohuaxian
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04334265 | Apr → Jun 2020 | COVID-19 | Peking University First Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anluohuaxian | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04334265 ↗ |
| Known as | Anluohuaxian Pill | “This has been successfully treated with the Anluohuaxian Pill, a proprietary Chinese medicine composed of a variety of Chinese herbal medicines.” PMID 32513299 ↗ Jun 2020 |
| Modality | Traditional medicine (herbal / TCM) | “a proprietary Chinese medicine composed of a variety of Chinese herbal medicines.” PMID 32513299 ↗ Jun 2020 |